Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, announced today that it will report ...

Helio Genomics and Quest Diagnostics have partnered to expand access to a blood-based liver cancer test across the U.S. Starting in April, providers with a Quest account will be able to order ...

Helio Genomics, an AI-powered TechBio company focused on early cancer detection, today announced an agreement with Quest Diagnostics, a leading provider of diagnostic information services, to ...

Quest Diagnostics recently unveiled a suite of advanced diagnostics and support services designed to broaden access to lab tests for transplants. Quest hopes to improve testing compliance among ...

Quest Diagnostics has outpaced its healthcare peers over the past year, and analysts are maintaining a moderately positive ...

Quest Diagnostics (NYSE:DGX) reported its second-quarter 2025 results on July 22, achieving consolidated revenue of $2.76 billion (up 15.2% year over year), organic revenue growth of 5.2%, while ...

The deal expands the local firm’s footprint as Quest exits market. #NewsismyBusiness - Stay updated with the latest Puerto Rico business news, economy insights, finance, retail, tourism, and more from ...

Quest Diagnostics is a dominant player in the growing medical testing industry, offering consistent earnings and dividend growth with lower volatility. DGX benefits from secular tailwinds like aging ...

Quest Diagnostics may be the preferred lab your health insurance, doctors, or specialists use for blood work or other samples. We’re reviewing its sub-brand Quest Health, from which you can order your ...

A month has gone by since the last earnings report for Quest Diagnostics (DGX). Shares have lost about 4.2% in that time frame, underperforming the S&P 500. Will the recent negative trend continue ...